Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.12% |
| 2 | Technology | 11.12% |
| 3 | Financials | 10.62% |
| 4 | Consumer Discretionary | 8.46% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
2626
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.28M | ﹤0.01% |
38,716
+19,250
| +99% | +$601K |
|
2627
Madrigal Pharmaceuticals
MDGL
$12.4B
| $1.28M | ﹤0.01% |
12,231
+7,120
| +139% | +$763K |
|
2628
PUT
Insmed
INSM
$22.5B
| $1.28M | ﹤0.01% |
+50,000
| New | +$1.39M |
|
2629
Gorman-Rupp
GRC
$2.09B
| $1.28M | ﹤0.01% |
38,956
-16,428
| -30% | -$534K |
|
|
WCC
2630
WESCO International
WCC
$15.2B
| $1.28M | ﹤0.01% |
25,261
-159,324
| -86% | -$8.34M |
|
2631
Tetra Tech
TTEK
$8.93B
| $1.28M | ﹤0.01% |
81,285
-742,245
| -90% | -$10M |
|
|
PNNT
2632
Pennant Park Investment Corp
PNNT
$222M
| $1.27M | ﹤0.01% |
+201,046
| New | +$1.35M |
|
2633
Antero Midstream
AM
$10.3B
| $1.27M | ﹤0.01% |
110,815
-2,128,783
| -95% | -$27.3M |
|
2634
Iridium Communications
IRDM
$4.7B
| $1.27M | ﹤0.01% |
+54,614
| New | +$1.36M |
|
|
GBT
2635
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.27M | ﹤0.01% |
24,136
-115,406
| -83% | -$6.63M |
|
|
ALEX
2636
DELISTED
Alexander & Baldwin
ALEX
| $1.27M | ﹤0.01% |
54,952
+46,915
| +584% | +$1.11M |
|
2637
CALL
Globus Medical
GMED
$10.9B
| $1.27M | ﹤0.01% |
30,000
+10,000
| +50% | +$434K |
|
|
VER
2638
DELISTED
VEREIT, Inc.
VER
| $1.27M | ﹤0.01% |
+28,147
| New | +$1.22M |
|
2639
Natural Health Trends
NHTC
$13.7M
| $1.26M | ﹤0.01% |
157,035
+68,395
| +77% | +$715K |
|
2640
Tootsie Roll Industries
TR
$3B
| $1.26M | ﹤0.01% |
42,074
+4,285
| +11% | +$134K |
|
2641
Liberty Media Series C
FWONK
$25.5B
| $1.26M | ﹤0.01% |
+34,799
| New | +$1.26M |
|
2642
PUT
Honeywell
HON
$76.3B
| $1.26M | ﹤0.01% |
60,689
+212
| +0.4% | +$33.7K |
|
2643
AC Immune
ACIU
$230M
| $1.25M | ﹤0.01% |
225,974
+56,215
| +33% | +$286K |
|
2644
CALL
MPLX
MPLX
$60.2B
| $1.25M | ﹤0.01% |
+38,900
| New | +$1.24M |
|
2645
Simulations Plus
SLP
$371M
| $1.25M | ﹤0.01% |
+43,645
| New | +$1.06M |
|
|
AEL
2646
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.24M | ﹤0.01% |
45,806
-58,258
| -56% | -$1.67M |
|
|
ORBC
2647
DELISTED
ORBCOMM, Inc.
ORBC
| $1.24M | ﹤0.01% |
171,608
-45,297
| -21% | -$322K |
|
2648
Kulicke & Soffa
KLIC
$4.3B
| $1.24M | ﹤0.01% |
55,064
+37,064
| +206% | +$814K |
|
2649
Scholastic
SCHL
$773M
| $1.24M | ﹤0.01% |
37,364
-8,280
| -18% | -$309K |
|
|
SCHW
2650
PUT
Charles Schwab
SCHW
$184B
| $1.24M | ﹤0.01% |
+30,800
| New | +$1.34M |
|
Similar funds
Millennium Management's Q2 2019 Portfolio in Review
As of Q2 2019, Millennium Management held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Millennium Management's Q2 2019 filing shows 865 new, 1,488 increased, 1,571 reduced and 810 closed positions. Its largest new stake was Moody's: 638,271 shares worth $125M. The largest sale was Walt Disney, an estimated $568M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
- Millennium Management's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Millennium Management added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Millennium Management's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Millennium Management fully exited Sysco in Q2 2019, selling an estimated $208M.
- Millennium Management's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Millennium Management opened 865 new positions and closed 810 in Q2 2019.
- Millennium Management's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.